We found that SRC-3 mechanistically exerted this role through interactions with the histone methyltransferase NSD2 to stabilize SRC-3 and form liquid–liquid phase separation, consequentially remodeling chromatin and producing an adaptive transcriptome favoring myeloma-cell survival and disease progression. The gene discussed is NCOA3; the disease is plasma cell myeloma.